ADAM10 and prostate carcinoma: Even before the promoter of human ADAM10 was described, several pathways regulating the enzyme's expression had been identified: for example, in the prostate cancer cell line LNCaP insulin-like growth factor I combined with 5 alpha-dihydrotestosterone increased mature and immature ADAM10 protein amounts (McCulloch et al., 2004).